US Stock MarketDetailed Quotes

ARDX Ardelyx

Watchlist
  • 6.7500
  • -0.6900-9.27%
Close May 24 16:00 ET
  • 6.9900
  • +0.2400+3.56%
Post 19:58 ET
1.58BMarket Cap-24107P/E (TTM)

About Ardelyx Company

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Company Profile

SymbolARDX
Company NameArdelyx
Listing DateJun 19, 2014
Issue Price14.00
Founded2007
CEOMr. Michael G. Raab
MarketNASDAQ
Employees267
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address400 Fifth Avenue,Suite 210
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-510-745-1700

Company Executives

  • Name
  • Position
  • Salary
  • Michael G. Raab
  • Director, President and Chief Executive Officer
  • 4.12M
  • Justin A. Renz
  • Chief Financial and Operations Officer
  • --
  • David P. Rosenbaum
  • Chief Development Officer
  • --
  • Susan Rodriguez
  • Chief Commercial Officer
  • --
  • Robert Felsch
  • Chief Accounting Officer
  • --
  • Elizabeth Grammer
  • Chief Legal and Administrative Officer
  • 1.63M
  • Robert Blanks
  • Chief Regulatory Affairs and Quality Assurance Officer
  • --
  • Dr. Laura Willia M.D.
  • Chief Medical Officer
  • 1.63M
  • Mike Kelliher
  • Executive Vice President, Corporate Development and Strategy
  • --
  • David M. Mott
  • Chairman of the Board
  • 249.90K
  • Onaiza Cadoret-Manier
  • Independent Director
  • 199.90K
  • Muna Bhanji, Ph.
  • Independent Director
  • 202.40K
  • Richard J. Rodgers
  • Independent Director
  • 222.40K
  • William C. Bertrand, Esq.,Jr
  • Independent Director
  • 214.90K
  • Dr. Jan M. Lundberg, PhD
  • Independent Director
  • 199.90K
  • Robert B. Bazemore, Jr
  • Independent Director
  • 202.40K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg